SMG Jan 2025 30.000 call
| Previous Close | 36.46 |
| Open | 38.28 |
| Bid | 36.00 |
| Ask | 40.40 |
| Strike | 30.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 36.37 - 38.28 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
ZacksScotts (SMG) Lowers FY24 EBITDA Guidance, Affirms FCF View
Scotts Miracle-Gro (SMG) lowers fiscal 2024 guidance for EBITDA and sales, citing weaker-than-expected May performance while reaffirming cost-saving and debt-reduction goals.
- Market Exclusive
Weekly Roundup on the Cannabis Sector & Psychedelic Sector week of 6-10-24
Key Takeaways; Cannabis Sector Canopy Growth to fully acquire Acreage Holdings in strategic move AFC Gamma exited its largest portfolio loan, securing 19.9% return. Green Thumb CEO confirmed proposal to Boston Beer. Scotts Miracle-Gro adjusted financial outlook for 2024 but maintained strategic goals. Key Takeaways; Psychedelic Sector Filament Health received FDA approval for a meth […]
GlobeNewswireScottsMiracle-Gro updates fiscal ’24 guidance at peak of lawn and garden season
Reaffirms two-year free cash flow target of $1 billion, debt paydown of $350 million in fiscal ’24 and full-year non-GAAP gross margin improvement of 250 bpsExpects to reduce leverage to below 5 times EBITDA by fiscal year-endProjects non-GAAP adjusted EBITDA in range of $530 to $540 million, an approximate 20-percent improvement over prior yearAnticipates mid single-digit growth in core consumer business versus prior year MARYSVILLE, Ohio, June 06, 2024 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gr
